Inventor · disambiguated record
Melvyn Little
Also filed as: LITTLE MELVYN
23 granted patents·13 pending applications·853 citations·filing 1992–2021
97Inventor score
Files withDEUTSCHES KREBSFORSCH7AFFIMED GMBH5AMPHIVENA THERAPEUTICS INC4LITTLE MELVYN4AFFIMED THERAPEUTICS AG3
Top patents by PatentIndex Score
36 records- 0195US7129330B1Multivalent antibody constructsDEUTSCHES KREBSFORSCH·Filed 1999·Granted Oct 31, 2006·240 cites·4 claims
- 0293US6730483B2Phagemid for antibody screeningDEUTSCHES KREBSFORSCH·Filed 2002·Granted May 4, 2004·32 cites·11 claims
- 0392US9212225B1Bispecific CD33 and CD3 binding proteinsAMPHIVENA THERAPEUTICS INC·Filed 2015·Granted Dec 15, 2015·17 cites·14 claims
- 0492US9035026B2Anti-CD16 binding moleculesHOFFMANN KARIN·Filed 2006·Granted May 19, 2015·54 cites·21 claims
- 0591US6127132APhagemid library for antibody screeningDEUTSCHES KREBSFORSCH·Filed 1999·Granted Oct 3, 2000·66 cites·6 claims
- 0690US9803029B2Bispecific CD33 and CD3 binding proteinsAMPHIVENA THERAPEUTICS INC·Filed 2015·Granted Oct 31, 2017·11 cites·18 claims
- 0790US5849500APhagemid for antibody screeningDEUTSCHES KREBSFORSCH·Filed 1992·Granted Dec 15, 1998·72 cites·7 claims
- 0889US9701750B2Anti-CD16 binding moleculesAFFIMED GMBH·Filed 2015·Granted Jul 11, 2017·11 cites·16 claims
- 0989US7507796B2Multivalent antibody constructsDEUTSCHES KREHSFORSCHUNGSZENTR·Filed 2006·Granted Mar 24, 2009·24 cites·11 claims
- 1088US10626190B2Bispecific CD33 and CD3 binding proteinsAMPHIVENA THERAPEUTICS INC·Filed 2017·Granted Apr 21, 2020·3 cites·12 claims
- 1188US6387627B1Phagemid for antibody screeningDEUTSCHES KREBSFORSCH·Filed 2000·Granted May 14, 2002·28 cites·8 claims
- 1286US5985588APhagemid for antibody screeningDEUTSCHES KREBSFORSCH·Filed 1998·Granted Nov 16, 1999·40 cites·8 claims
- 1386US5840479APreparation and use of gene banks of synthetic human antibodies ("synthetic human-antibody libraries")BEHRING DIAGNOSTICS GMBH·Filed 1994·Granted Nov 24, 1998·115 cites·54 claims
- 1485US10066015B2CD3 binding domainsAFFIMED GMBH·Filed 2015·Granted Sep 4, 2018·10 cites·11 claims
- 1583US6319690B1Preparation and use of gene banks of human antibodies (“human-antibody libraries”)DADE BEHRING MARBURG GMBH·Filed 1993·Granted Nov 20, 2001·89 cites·16 claims
- 1680US7812136B2Antibody of human origin specifically binding to activated state of platelet integrin receptor GPIIb/IIIaAFFIMED THERAPEUTICS AG·Filed 2002·Granted Oct 12, 2010·18 cites·7 claims
- 1776US8148496B2Multivalent antibody constructsLITTLE MELVYN·Filed 2009·Granted Apr 3, 2012·3 cites·6 claims
- 1874US10273309B2Antibody binding sites specific for EGFRvIIIAFFIMED GMBH·Filed 2016·Granted Apr 30, 2019·2 cites·21 claims
- 1969US7901677B1Use of an antibody against the laminin receptor or laminin receptor precursor for the treatment or diagnosis of several cancer typesAFFIMED THERAPEUTICS AG·Filed 2006·Granted Mar 8, 2011·1 cites·13 claims
- 2065US2021024654A1Bispecific CD33 and CD3 Binding ProteinsAMPHIVENA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2163US2018346590A1Antigen-binding molecule and uses thereofAffimed GmbBH·Filed 2018·Application pending·0 cites
- 2261US9365647B2Compounds for use in the treatment of Alzheimer's diseaseWEISS STEFAN FRANZ THOMAS·Filed 2012·Granted Jun 14, 2016·1 cites·4 claims
- 2361US8455627B2Human antibody specific for activated state of platelet integrin receptor GPIIb/IIIaLINHARD CLAUDIA·Filed 2010·Granted Jun 4, 2013·2 cites·4 claims
- 2456US2015225484A1Antigen-binding molecule and uses thereofAFFIMED GMBH·Filed 2015·Application pending·0 cites
- 2556US2022048994A1Trifunctional antigen-binding moleculeLITTLE MELVYN·Filed 2021·Application pending·0 cites
- 2656US2013189263A1Antigen-binding molecule and uses thereofLITTLE MELVYN·Filed 2012·Application pending·0 cites
- 2756US2008145362A1Antibody combination useful for tumor therapyAFFIMED THERAPEUTICS AG·Filed 2008·Application pending·0 cites
- 2852US5591604ARecombinant antibodies at the surface of E. coliDEUTSCHES KREBSFORSCH·Filed 1992·Granted Jan 7, 1997·10 cites·6 claims
- 2951US2011206672A1Antigen-Binding Molecule And Uses ThereofLITTLE MELVYN·Filed 2011·Application pending·0 cites
- 3049US2005089519A1Bispecific anti-cd19x anti-cd16 antibodies and uses thereofFiled 2002·Application pending·0 cites
- 3147US2005079170A1Dimeric and multimeric antigen binding structureFiled 2002·Application pending·0 cites
- 3247US2005176934A1Antibody combination useful for tumor therapyFiled 2003·Application pending·0 cites
- 3346US2016361413A1Compounds for use in the treatment of alzheimer's diseaseUNIV JOHANNESBURG WITWATERSRAND·Filed 2016·Application pending·0 cites
- 3442US2017037128A1Trifunctional antigen-binding moleculeAFFIMED GMBH·Filed 2016·Application pending·0 cites
- 3539US2004175786A1Anti-cd3 single-chain antibodies having human cmu3 and cmu4 domainsFiled 2001·Application pending·0 cites
- 3630US5911987ACell surface protein and effector cell bonding reagentSCHIRRMACHER VOLKER·Filed 1995·Granted Jun 15, 1999·4 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when Melvyn Little files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →